What's new?

Added 17 hours ago Drug news

AstraZeneca licenses rights to Movantik to RedHill Biopharma, a treatment for opioid induced constipation.

AstraZeneca has agreed to sublicense its global rights to Movantik (naloxegol), excluding Europe, Canada and Israel, to RedHill Biopharma (RedHill)....

Added 17 hours ago Drug news

FDA 510K approval for Novalung to treat long term acute respiratory/cardiopulmonary failure. Xenios AG/ Fresenius

The FDA has granted 510(k) approval to the Novalung system for long-term respiratory/cardiopulmonary support in patients with acute respiratory failure...

Added 1 day ago Drug news

Phase III INCREASE study of Tyvaso meets primary endpoint in pulmonary hypertension with interstitial lung disease.- United Therapeutics

United Therapeutics announced that preliminary analysis indicates that the phase III INCREASE clinical study of Tyvaso (treprostinil) Inhalation Solution in...

Added 1 day ago Drug news

FDA and EMA accept filings of subcutaneous ofatumumab for the treatment of relapsing Multiple Sclerosis.- Genmab A/S + Novartis

Genmab A/S announced that the FDA has accepted, with priority review, the supplemental Biologics License Application (sBLA) submitted by Novartis...

Added 2 days ago Drug news

FDA accepts NDA for Libervant Buccal Film for the treatment of seizure clusters. -Aquestive Therapeutics.

Aquestive Therapeutics, Inc. announced that, as anticipated, the FDA accepted the Company’s New Drug Application (NDA) for Libervant (diazepam) Buccal...